Stock Information
Prime Medicine Inc (PRME)
Ticker Symbol: PRME
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $599.30 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.3786
Revenue (TTM): $0.03 M
Dividend Yield: N/A%
ROE: -178.61%
Latest News
-
Prime Medicine (NASDAQ:PRME) Q1 Results Show Revenue Miss and Narrower Loss as Key Pipeline Milestones Loom
Thu, May 7, 2026 1:22 PM
-
Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 12:21 PM
-
Prime Medicine Q1 EPS $(0.28) Misses $(0.25) Estimate, Sales $856.000K Miss $1.065M Estimate
Thu, May 7, 2026 8:17 AM
-
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
Thu, May 7, 2026 8:01 AM
Key Financials
Financial data not available
